EMEA (Europe, Middle East and Africa) Biologic Drugs Market Report 2017

October 2017 | 105 pages | ID: EE713E0EA21PEN
QYResearch

Abstracts

In this report, the EMEA Biologic Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Biologic Drugs for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biologic Drugs market competition by top manufacturers/players, with Biologic Drugs sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche
• Abbott Laboratories
• Johnson & Johnson
• Merck & Co.
• Pfizer
• Amgen
• Sanofi
• Novartis
• Eli Lilly
• Amgen

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Humira
• Remicade
• Rituxan
• Enbrel
• Lantus
• Avastin
• Herceptin
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Biologic Drugs for each application, including

• Diabetes
• Inflammation
• Auto-Immune Diseases
• Blood Diseases
• Cardiovascular Diseases
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Biologic Drugs Market Report 2017

1 BIOLOGIC DRUGS OVERVIEW

1.1 Product Overview and Scope of Biologic Drugs
1.2 Classification of Biologic Drugs
  1.2.1 EMEA Biologic Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Biologic Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Humira
  1.2.4 Remicade
  1.2.5 Rituxan
  1.2.6 Enbrel
  1.2.7 Lantus
  1.2.8 Avastin
  1.2.9 Herceptin
  1.2.10 Others
1.3 EMEA Biologic Drugs Market by Application/End Users
  1.3.1 EMEA Biologic Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Diabetes
  1.3.3 Inflammation
  1.3.4 Auto-Immune Diseases
  1.3.5 Blood Diseases
  1.3.6 Cardiovascular Diseases
  1.3.7 Others
1.4 EMEA Biologic Drugs Market by Region
  1.4.1 EMEA Biologic Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biologic Drugs (2012-2022)
  1.5.1 EMEA Biologic Drugs Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Biologic Drugs Revenue and Growth Rate (2012-2022)

2 EMEA BIOLOGIC DRUGS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Biologic Drugs Market Competition by Players/Manufacturers
  2.1.1 EMEA Biologic Drugs Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Biologic Drugs Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Biologic Drugs Sale Price by Players (2012-2017)
2.2 EMEA Biologic Drugs (Volume and Value) by Type/Product Category
  2.2.1 EMEA Biologic Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Biologic Drugs Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Biologic Drugs Sale Price by Type (2012-2017)
2.3 EMEA Biologic Drugs (Volume) by Application
2.4 EMEA Biologic Drugs (Volume and Value) by Region
  2.4.1 EMEA Biologic Drugs Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Biologic Drugs Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Biologic Drugs Sales Price by Region (2012-2017)

3 EUROPE BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Biologic Drugs Sales and Value (2012-2017)
  3.1.1 Europe Biologic Drugs Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Biologic Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Biologic Drugs Sales and Market Share by Type
3.3 Europe Biologic Drugs Sales and Market Share by Application
3.4 Europe Biologic Drugs Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Biologic Drugs Sales Volume by Countries (2012-2017)
  3.4.2 Europe Biologic Drugs Revenue by Countries (2012-2017)
  3.4.3 Germany Biologic Drugs Sales and Growth Rate (2012-2017)
  3.4.4 France Biologic Drugs Sales and Growth Rate (2012-2017)
  3.4.5 UK Biologic Drugs Sales and Growth Rate (2012-2017)
  3.4.6 Russia Biologic Drugs Sales and Growth Rate (2012-2017)
  3.4.7 Italy Biologic Drugs Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Biologic Drugs Sales and Growth Rate (2012-2017)

4 MIDDLE EAST BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Biologic Drugs Sales and Value (2012-2017)
  4.1.1 Middle East Biologic Drugs Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Biologic Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Biologic Drugs Sales and Market Share by Type
4.3 Middle East Biologic Drugs Sales and Market Share by Application
4.4 Middle East Biologic Drugs Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Biologic Drugs Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Biologic Drugs Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Biologic Drugs Sales and Growth Rate (2012-2017)
  4.4.4 Israel Biologic Drugs Sales and Growth Rate (2012-2017)
  4.4.5 UAE Biologic Drugs Sales and Growth Rate (2012-2017)
  4.4.6 Iran Biologic Drugs Sales and Growth Rate (2012-2017)

5 AFRICA BIOLOGIC DRUGS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Biologic Drugs Sales and Value (2012-2017)
  5.1.1 Africa Biologic Drugs Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Biologic Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Biologic Drugs Sales and Market Share by Type
5.3 Africa Biologic Drugs Sales and Market Share by Application
5.4 Africa Biologic Drugs Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Biologic Drugs Sales Volume by Countries (2012-2017)
  5.4.2 Africa Biologic Drugs Revenue by Countries (2012-2017)
  5.4.3 South Africa Biologic Drugs Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Biologic Drugs Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Biologic Drugs Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Biologic Drugs Sales and Growth Rate (2012-2017)

6 EMEA BIOLOGIC DRUGS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biologic Drugs Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Laboratories
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Biologic Drugs Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Laboratories Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Biologic Drugs Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Johnson & Johnson Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Merck & Co.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Biologic Drugs Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Merck & Co. Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Biologic Drugs Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Pfizer Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Amgen
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Biologic Drugs Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Sanofi
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Biologic Drugs Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Sanofi Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Novartis
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Biologic Drugs Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Novartis Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Eli Lilly
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Biologic Drugs Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Eli Lilly Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Amgen
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Biologic Drugs Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Amgen Biologic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 BIOLOGIC DRUGS MANUFACTURING COST ANALYSIS

7.1 Biologic Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biologic Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biologic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biologic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA BIOLOGIC DRUGS MARKET FORECAST (2017-2022)

11.1 EMEA Biologic Drugs Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Biologic Drugs Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Biologic Drugs Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Biologic Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Biologic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biologic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biologic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biologic Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biologic Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Biologic Drugs Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Biologic Drugs
Figure EMEA Biologic Drugs Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Biologic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Humira Product Picture
Figure Remicade Product Picture
Figure Rituxan Product Picture
Figure Enbrel Product Picture
Figure Lantus Product Picture
Figure Avastin Product Picture
Figure Herceptin Product Picture
Figure Others Product Picture
Figure EMEA Biologic Drugs Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Biologic Drugs by Application in 2016
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Inflammation Examples
Table Key Downstream Customer in Inflammation
Figure Auto-Immune Diseases Examples
Table Key Downstream Customer in Auto-Immune Diseases
Figure Blood Diseases Examples
Table Key Downstream Customer in Blood Diseases
Figure Cardiovascular Diseases Examples
Table Key Downstream Customer in Cardiovascular Diseases
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Biologic Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biologic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biologic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biologic Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biologic Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biologic Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Biologic Drugs Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Biologic Drugs Sales Share by Players (2012-2017)
Figure 2016 Biologic Drugs Sales Share by Players
Figure 2017 Biologic Drugs Sales Share by Players
Figure EMEA Biologic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biologic Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Biologic Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Biologic Drugs Revenue Share by Players
Table 2017 EMEA Biologic Drugs Revenue Share by Players
Table EMEA Biologic Drugs Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Biologic Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Biologic Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologic Drugs by Type (2012-2017)
Figure EMEA Biologic Drugs Sales Market Share by Type (2012-2017)
Table EMEA Biologic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biologic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Type in 2016
Table EMEA Biologic Drugs Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Biologic Drugs Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Biologic Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Biologic Drugs by Application (2012-2017)
Figure EMEA Biologic Drugs Sales Market Share by Application in 2016
Table EMEA Biologic Drugs Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Biologic Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Biologic Drugs by Region (2012-2017)
Figure EMEA Biologic Drugs Sales Market Share in 2016
Table EMEA Biologic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biologic Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biologic Drugs by Region (2012-2017)
Figure EMEA Biologic Drugs Revenue Market Share Regions in 2016
Table EMEA Biologic Drugs Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Biologic Drugs Revenue and Growth Rate (2012-2017)
Table Europe Biologic Drugs Sales (K Units) by Type (2012-2017)
Table Europe Biologic Drugs Market Share by Type (2012-2017)
Figure Europe Biologic Drugs Market Share by Type in 2016
Table Europe Biologic Drugs Sales (K Units) by Application (2012-2017)
Table Europe Biologic Drugs Market Share by Application (2012-2017)
Figure Europe Biologic Drugs Market Share by Application in 2016
Table Europe Biologic Drugs Sales (K Units) by Countries (2012-2017)
Table Europe Biologic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Biologic Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Biologic Drugs Sales Market Share by Countries in 2016
Table Europe Biologic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Biologic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Biologic Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Biologic Drugs Revenue Market Share by Countries in 2016
Figure Germany Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure France Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UK Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biologic Drugs Sales (K Units) by Type (2012-2017)
Table Middle East Biologic Drugs Market Share by Type (2012-2017)
Figure Middle East Biologic Drugs Market Share by Type (2012-2017)
Table Middle East Biologic Drugs Sales (K Units) by Applications (2012-2017)
Table Middle East Biologic Drugs Market Share by Applications (2012-2017)
Figure Middle East Biologic Drugs Sales Market Share by Application in 2016
Table Middle East Biologic Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Biologic Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biologic Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Biologic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biologic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Biologic Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Biologic Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Biologic Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biologic Drugs Sales (K Units) by Type (2012-2017)
Table Africa Biologic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Biologic Drugs Sales Market Share by Type (2012-2017)
Figure Africa Biologic Drugs Sales Market Share by Type in 2016
Table Africa Biologic Drugs Sales (K Units) by Application (2012-2017)
Table Africa Biologic Drugs Sales Market Share by Application (2012-2017)
Figure Africa Biologic Drugs Sales Market Share by Application (2012-2017)
Table Africa Biologic Drugs Sales Volume (K Units) by Countries (2012-2017)
Table Africa Biologic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Biologic Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Biologic Drugs Sales Market Share by Countries in 2016
Table Africa Biologic Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Biologic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Biologic Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Biologic Drugs Revenue Market Share by Countries in 2016
Figure South Africa Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Table Roche Biologic Drugs Basic Information List
Table Roche Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Roche Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Biologic Drugs Basic Information List
Table Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Laboratories Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Abbott Laboratories Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biologic Drugs Basic Information List
Table Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Merck & Co. Biologic Drugs Basic Information List
Table Merck & Co. Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co. Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Merck & Co. Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Merck & Co. Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Biologic Drugs Basic Information List
Table Pfizer Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Pfizer Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen Biologic Drugs Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Amgen Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi Biologic Drugs Basic Information List
Table Sanofi Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Novartis Biologic Drugs Basic Information List
Table Novartis Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Novartis Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biologic Drugs Basic Information List
Table Eli Lilly Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Eli Lilly Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Amgen Biologic Drugs Basic Information List
Table Amgen Biologic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Biologic Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Amgen Biologic Drugs Sales Market Share in EMEA (2012-2017)
Figure Amgen Biologic Drugs Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologic Drugs
Figure Manufacturing Process Analysis of Biologic Drugs
Figure Biologic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Biologic Drugs Major Manufacturers in 2016
Table Major Buyers of Biologic Drugs
Table Distributors/Traders List
Figure EMEA Biologic Drugs Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Biologic Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biologic Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Biologic Drugs Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Biologic Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biologic Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biologic Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biologic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Biologic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biologic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biologic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biologic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Biologic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biologic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biologic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biologic Drugs Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Biologic Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biologic Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biologic Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biologic Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Biologic Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biologic Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Biologic Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources